These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18365787)

  • 1. [Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report].
    Díaz-Marsá M; Galian M; Montes A; Fernández R; Arza R; López-Ibor J; Carrasco J
    Actas Esp Psiquiatr; 2008; 36(2):70-4. PubMed ID: 18365787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting risperidone in stable patients with schizoaffective disorder.
    Mohl A; Westlye K; Opjordsmoen S; Lex A; Schreiner A; Benoit M; Bräunig P; Medori R
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder].
    Benabarre A; Castro P; Sánchez-Moreno J; Martínez-Arán A; Salamero M; Murru A; Franco C; Vieta E
    Actas Esp Psiquiatr; 2009; 37(3):143-7. PubMed ID: 19533426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone.
    Llorca PM; Bouhours P; Moreau-Mallet V;
    Encephale; 2008 Apr; 34(2):170-8. PubMed ID: 18597725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.
    Han C; Lee MS; Pae CU; Ko YH; Patkar AA; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1219-23. PubMed ID: 17532106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience and management considerations with long-acting risperidone.
    Parellada E
    Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.
    Vieta E; Nieto E; Autet A; Rosa AR; Goikolea JM; Cruz N; Bonet P
    World J Biol Psychiatry; 2008; 9(3):219-24. PubMed ID: 18609430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA; Katsafouros K; Möller HJ; Medori R; Sacchetti E
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
    Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
    Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical global impression scale for borderline personality disorder patients (CGI-BPD): a scale sensible to detect changes.
    Perez V; Barrachina J; Soler J; Pascual JC; Campins MJ; Puigdemont D; Alvarez E
    Actas Esp Psiquiatr; 2007; 35(4):229-35. PubMed ID: 17592784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.